|Corn||Old Crop||New Crop|
|Pro Coop, Pocahontas||-.48||-.55|
|Lakota Ethanol - GPRE, Lakota||-.45||-.50|
|CFE, George IA||-.40||-.51|
|Green Plains Renewable, Superior||-.45||-.45|
|Stateline Co-op, Halfa||-.35||-.54|
|Don's Farm Supply, Newell||-.31||-.37|
|Poet Bio Refining, Emmetsburg||-.32||-.45|
|Max Yield, Fostoria||-.50||-.55|
|Max Yield, Mallard||-.50||-.55|
|Max Yield, Kerber||-.35||-.45|
|Soybeans||Old Crop||New Crop|
|Pro Coop, Pocahontas||-.83||-.80|
|Don's Farm Supply, Newell||-.85||-.77|
|Stateline Co-op, Halfa||-.78||-.88|
|Meadowland Co-op, Lamberton,MN||-.85||-.80|
|CFE, George IA||-.86||-.88|
|First Co-op, Laurens||-.82||-.82|
|Max Yield, Fostoria||-.83||-.86|
|Max Yield, Mallard||-.83||-.86|
|Ag Partners, Emmetsburg||-.83||-.82|
October 19, 2017 10:42 AM
LONDON – When Aaron Blair sat down to chair a week-long meeting of 17 specialists at the International Agency for Research on Cancer in France in March 2015, there was something he wasn’t telling them.
The epidemiologist from the U.S. National Cancer Institute had seen important unpublished scientific data relating directly to a key question the IARC specialists were about to consider: Whether research shows that the weedkiller glyphosate, a key ingredient in Monsanto’s best-selling RoundUp brand, causes cancer.
Previously unreported court documents reviewed by Reuters from an ongoing U.S. legal case against Monsanto show that Blair knew the unpublished research found no evidence of a link between glyphosate and cancer. In a sworn deposition given in March this year in connection with the case, Blair also said the data would have altered IARC’s analysis. He said it would have made it less likely that glyphosate would meet the agency’s criteria for being classed as “probably carcinogenic.”
But IARC, a semi-autonomous part of the World Health Organization, never got to consider the data. The agency’s rules on assessing substances for carcinogenicity say it can consider only published research – and this new data, which came from a large American study on which Blair was a senior researcher, had not been published.
The lack of publication has sparked debate and contention. A leading U.S. epidemiologist and a leading UK statistician – both independent of Monsanto – told Reuters the data was strong and relevant and they could see no reason why it had not surfaced.
Monsanto told Reuters that the fresh data on glyphosate could and should have been published in time to be considered by IARC, and that the failure to publish it undermined IARC’s classification of glyphosate. The legal case against Monsanto, taking place in California, involves 184 individual plaintiffs who cite the IARC assessment and claim exposure to RoundUp gave them cancer. They allege Monsanto failed to warn consumers of the risks. Monsanto denies the allegations.
The company also goes beyond saying the fresh data should have been published. It told Reuters the data was deliberately concealed by Blair, but provided no specific evidence of it being hidden.
Blair told Reuters the data, which was available two years before IARC assessed glyphosate, was not published in time because there was too much to fit into one scientific paper. Asked whether he deliberately did not publish it to avoid it being considered by IARC, he said that was “absolutely incorrect.” He said a decision not to publish the glyphosate data had been taken "several months" before IARC chose to conduct a review of the chemical.
The National Cancer Institute also cited “space constraints” as the reasons why the new data on glyphosate was not published.
The absence of the data from IARC’s assessment was important. IARC ended its meeting in 2015 by concluding that glyphosate is a “probable human carcinogen.” It based its finding on “limited evidence” of carcinogenicity in humans and “sufficient evidence” in experimental animals. It said, among other things, that there was a “positive association” between glyphosate and blood cancers called non-Hodgkin lymphoma. IARC told Reuters that, despite the existence of fresh data about glyphosate, it was sticking with its findings.
The agency’s assessment is at odds with other international regulators who have said the weedkiller is not a carcinogenic risk to humans. It led to a delay in Europe on a decision on whether to re-license or ban EU-wide sales of pesticides containing glyphosate. That decision is still pending. In the meantime, some countries have tightened restrictions on the weedkiller’s use in private gardens and public spaces and on crops before harvest.
In the United States, a California judge took the IARC assessment into account in a separate legal case in March when ruling that the state can require RoundUp to carry a warning label that it may cause cancer. Monsanto is now facing further litigation from hundreds of plaintiffs across the United States who say glyphosate gave them or their loved ones non-Hodgkin lymphoma, citing the IARC assessment as part of their claims.
Yet if the IARC panel experts had been in a position to take into account Blair’s fresh data, IARC’s analysis of the evidence on glyphosate would have been different, Blair acknowledged in the court documents reviewed by Reuters.
The unpublished research came from the Agricultural Health Study, a large and significant study, led by scientists at the U.S. National Cancer Institute, of agricultural workers and their families in the United States. Asked by Monsanto lawyers in March whether the unpublished data showed "no evidence of an association” between exposure to glyphosate and non-Hodgkin lymphoma, Blair replied: "Correct."
Asked in the same deposition whether IARC's review of glyphosate would have been different if the missing data had been included, Blair again said: "Correct.” Lawyers had put to him that the addition of the missing data would have “driven the meta-relative risk downward,” and Blair agreed.
Scott Partridge, Monsanto’s vice president of strategy, told Reuters the IARC glyphosate review “ignored multiple years of additional data from the largest and most comprehensive study on farmer exposure to pesticides and cancer.”
October 3, 2017 11:06 AM
02-Oct-2017 04:57:47 PM
Recasts throughout; adds Ohio River reopening, grain elevator bids falling, analyst quote
By Karl Plume
CHICAGO, Oct 2 (Reuters) - U.S. farmers are running out of options for their just-harvested corn and soybeans as delays on the Mississippi River, the main conduit for crops to export markets, cause shipping backlogs, while grain storage on the river's banks is filling up.
Low river levels and back-ups at ageing locks have slowed navigation on the Mississippi and its tributaries and driven the cost of hauling Midwestern crops to Gulf Coast export terminals to near-record highs.
As newly harvested supplies reach the market, elevators with barges on hand are prioritizing loading soybeans while storing corn if they have space, traders and barge brokers said.
Cash soybean premiums at several large river terminals in the St. Louis area fell to the lowest point since at least 2011, while soy processors and inland elevators also dropped bids amid ample available supplies, grain merchants said.
"There are a lot of trickle down effects that are being felt throughout the whole industry. It starts with the low water on the rivers and the trouble getting bushels where they need to be in exporters' hands," said Terry Linn, analyst at Chicago brokerage Linn and Associates.
The grain handling woes come as farmers are beginning to harvest bumper corn and soybean crops amid weakening harvest-time prices, with soybean stocks at a decade high and corn supplies at the biggest in 29 years.
"People are running out of space. Everybody's been stuffing their bin space with corn and shipping beans. Now they can't find enough barges when they need them to move the beans," said a barge broker who asked not to be named.
Shippers that have barges on hand are loading them with less grain to keep them from grounding in parched rivers, while barge lines are reducing the number of barges per tow to navigate the narrower shipping channel.
Barges in the Memphis to Cairo, Illinois, market traded at an all-time high while spot barges on the lower Ohio river were booked at a level reached just once, in September 2014.
The lock has resumed operating, but a queue of more than 65 towboats was waiting to pass, a back-log that could take more than five days to clear, barge operator American Commercial Line said in a daily newsletter.
September 18, 2017 11:15 AM
Australia slashed more than 2.7m tonnes from its wheat export forecast, making deep cuts to expectations for canola and coarse grain shipments too, as it counted the cost of drought damage to its crops.
Abares, the official Australian crop bureau, lowered to 18.15m tonnes, from 20.89m tonnes, its forecast for the country's wheat exports in 2017-18, on a July-to-June basis.
The downgraded figure, below a 18.5m-tonne estimate from the US Department of Agriculture, would take shipments nearly 4m tonnes below last season's result.
And it reflected in part what Abares termed "severe moistures stress" for crops in the likes of Queensland and northern and central New South Wales, thanks to "unfavourably dry conditions".
"Exportable supplies are expected to decrease because of the smaller harvest," the bureau said.
The comments come amid an enhanced global wheat market focus on Australian prospects, given ideas of a record Russian harvest bumping up against infrastructure limits, so capping the country's expected rise in shipments.
Paris-based Agritel said that the "delicate situation in Australia is offering an element of support to international markets", in price terms.
US broker Benson Quinn Commodities said that Australia's woes "becomes a supportive piece" for US prices if they mean that extra "business materialises" for supplies of US hard red winter wheat.
However, Abares was cautious on importers' needs too, foreseeing a 3m tonnes in world trade because "wheat harvests in China, India, northern Africa and Turkey have improved in quality and volume.
"This has reduced demand for imports to meet the shortfall between domestic production and consumption."
Australia vs Ukraine
For canola, Abares cut its forecast for canola exports from Australia, the second-ranked shipper of the oilseed after Canada, by 510,000 tonnes to 2.04m tonnes for 2017-18.
The revision - which took to 43% the forecast decline in exports year on year – again followed a crop downgrade, with the bureau flagging in particular the dent to production prospects from "well-below-average rainfall in autumn and early winter" in top growing state Western Australia.
Abares also highlighted the prospect of reduced import needs in the European Union, the world's top consumer of rapeseed-canola, thanks to a bigger harvest, and the expectation of increased supplies from Ukraine, "a key competitor for Australia in that [EU] market".
In coarse grains, Abares also lowered its 2017-18 Australian export forecast – by 1.67m tonnes to 6.03m tonnes, the lowest in seven years.
For barley and oats, the decline again reflects drought damage to production.
However, in sorghum - of which Abares expects Australia to grow an extra 80%, representing extra sowings on land abandoned for winter crops – export growth will be curtailed by increased domestic demand.
Besides extra feeds needs of Australia's feedlot industry, now boasting more than 1m cattle on feed, demand for sorghum is being whetted by the introduction this year in Queensland, the sorghum and sugar-growing state, of an ethanol mandate of 3% of the biofuel in gasoline.
"The Queensland biofuel mandate will increase demand for grain sorghum and lead to higher prices for growers supplying the refinery.
"Increased domestic feed and industrial demand is expected to limit the volume [of sorghum] available for export."